Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhIL-2 gargle for pemphigus vulgaris
NCT04023149Phase 2Unknown
- Sponsor
- The Second Xiangya Hospital
- Start
- Apr 2020
- Primary completion
- Jun 2021
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of aldesleukin in pemphigus vulgaris (PV), sponsored by The Second Xiangya Hospital. Status: unknown.
02
Drugs
aldesleukin
03
Conditions
pemphigus vulgaris (PV)
Beyond the preview
Go deeper on NCT04023149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04023149.